UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in PTCT — Ptc Therapeutics, Inc.
CIK 861177
NEW YORK, NY
Position in PTCT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$10,278,713
+$1,628,728 QoQ
Shares Held
126,011
-0.7% QoQ
Ownership
0.151%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#76
of 383 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 42%
Shared 0%
None 58%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,443,898,601 across 206 Biotechnology names. PTCT ranks #39 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in PTCT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,278,713 | 126,011 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $8,649,985 | 126,963 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $10,018,588 | 131,893 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $7,971,837 | 129,898 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,217,176 | 229,672 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $9,109,350 | 178,755 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $7,233,727 | 160,251 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,970,545 | 133,977 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,660,449 | 152,402 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,300,929 | 79,097 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,179,910 | 79,097 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,697,017 | 75,726 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,988,836 | 73,490 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,559,854 | 73,490 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,590,558 | 67,869 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $13,150,843 | 261,969 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $11,066,772 | 276,255 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $17,431,452 | 467,206 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $19,126,921 | 480,214 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $17,760,702 | 477,310 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $19,461,106 | 460,400 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $14,972,161 | 316,202 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $27,105,982 | 444,142 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $19,982,818 | 427,440 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $24,953,016 | 491,782 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $16,420,313 | 368,086 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||